SectorPharmaceutical
Established Date22/01/2012
Listing Date31/07/2014
ExchangeNASDAQ Stock Exchange
Full-time Employees34
Fiscal Year Ends31/12
Security TypeCommon stock
Office address14 Einstein Street, Ness-Ziona, Israel 7403618
BusinessFocus on identifying, licensing, acquiring, developing and marketing drugs for the treatment of rare and rare genetic diseases.
IntroductionEnlivex Ltd., an Israeli company headquartered in Tel Aviv, was established on January 22, 2012. The company is a still developing biopharmaceutical company focused on identifying, licensing, acquiring, developing and marketing drugs for the treatment of rare and rare genetic diseases. The company seeks a solution that identifies the pathophysiological mechanisms common to several diseases included. The company focuses on the manifestations of rare diseases, has clear medical needs, and the biological mechanisms of action are well known, and there is no satisfactory treatment for them.
